Literature DB >> 4404909

Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents.

C W Parker, J W Smith.   

Abstract

In an effort to better define the role of betaadrenergic blockade in human bronchial asthma, peripheral blood leukocytes and lymphocytes from individuals with this condition were studied for possible alterations in cyclic AMP metabolism. Using a previously described radioimmunoassay to measure cyclic AMP, cells from asthmatic subjects were shown to have a highly significant decrease in their cyclic AMP response to beta-adrenergic agents (isoproterenol, norepinephrine, and epinephrine) by comparison with normal control cells. The alteration in responsiveness was most marked at the time of severe active asthma and returned toward normal during periods of clinical remission. Evidence was presented to indicate that the reduced response in cells from asthmatic individuals was not due to marked alterations in the proportion of T and B lymphocytes. Five normal volunteers were treated with an oral bronchodilator preparation containing theophylline and ephedrine over a 2 wk period without a significant change in the lymphocyte cyclic AMP response. These results provide unambiguous evidence for altered adrenergic responsiveness in bronchial asthma and indicate that purified peripheral blood lymphocytes should be a suitable in vitro system for further elucidation of the abnormality. Despite the reduction in catecholamine responsiveness in the asthmatic population as a whole, major alterations were largely restricted to individuals with severe, chronic asthma. Conclusive evidence for beta-adrenergic blockade in individuals who have not had recent asthmatic symptoms was not obtained, casting some doubt on the theory that bronchial asthma is due to a congenital derangement of cyclic AMP metabolism. Moreover, transient episodes of bronchospasm were often accompanied by a normal cyclic AMP response indicating that episodes of asthma frequently occur in the absence of easily demonstrable adrenergic blockade.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4404909      PMCID: PMC302226          DOI: 10.1172/JCI107173

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  A COMPARISON OF THE EFFECTS OF ISOPROTERENOL IN THE NORMAL AND ASTHMATIC SUBJECT. A PRELIMINARY REPORT.

Authors:  D U COOKSON; C E REED
Journal:  Am Rev Respir Dis       Date:  1963-11

2.  Comparison of the circulatory and metabolic effects of isoproterenol, epinephrine and methoxamine in normal and asthmatic subjects.

Authors:  M H Grieco; R N Pierson; F X Pi-Sunyer
Journal:  Am J Med       Date:  1968-06       Impact factor: 4.965

3.  Ribonucleic acid metabolism in lymphocytes stimulated by phytohemagglutinin. II. Rapidly synthesized ribonucleic acid and te production of ribosomal ribonucleic acid.

Authors:  H L Cooper
Journal:  J Biol Chem       Date:  1968-01-10       Impact factor: 5.157

4.  Comparison of some metabolic responses in normal and asthmatic subjects to epinephrine and glucagon.

Authors:  S D Lockey; J A Glennon; C E Reed
Journal:  J Allergy       Date:  1967-12

5.  Effects of epinephrine on asthmatic children. Effects of epinephrine on blood glucose, pulmonary function, and heart rate of children with asthma of varying severity.

Authors:  S Inoue
Journal:  J Allergy       Date:  1967-12

6.  Metabolic response to epinephrine in bronchial asthma.

Authors:  E Middleton; S R Finke
Journal:  J Allergy       Date:  1968-11

7.  Patterns of respiratory insufficiency.

Authors:  J G Scadding
Journal:  Lancet       Date:  1966-03-26       Impact factor: 79.321

8.  Fractionation of splenic antibody-forming cells on glass bead columns.

Authors:  P H Plotz; N Talal
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

9.  Radioimmunoassay for the measurement of adenosine 3',5'-cyclic phosphate.

Authors:  A L Steiner; D M Kipnis; R Utiger; C Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

10.  Cell separation on antigen-coated columns. Elimination of high rate antibody-forming cells and immunological memory cells.

Authors:  H Wigzell; B Andersson
Journal:  J Exp Med       Date:  1969-01-01       Impact factor: 14.307

View more
  61 in total

1.  Adrenoceptor responsiveness in bronchial asthma: effect of isoprenaline inhalation on plasma cyclic 3',5'-AMP levels.

Authors:  P W Trembath; J Shaw
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

2.  Management of asthma.

Authors:  O L Frick
Journal:  West J Med       Date:  1978-05

3.  Desensitization of the beta-adrenoceptor of lymphocytes from normal subjects and asthmatic patients in vitro.

Authors:  J K Greenacre; P Schofield; M E Conolly
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

4.  Desensitization of the beta-adrenoceptor of lymphocytes from normal subjects and patients with phaeochromocytoma: studies in vivo.

Authors:  J K Greenacre; M E Conolly
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

5.  Dose-dependent desensitization of lymphocyte beta-receptor function after long-term culture with isoprenaline [proceedings].

Authors:  M E Conolly; J K Greenacre; P Scofield
Journal:  Br J Pharmacol       Date:  1976-11       Impact factor: 8.739

6.  Alterations in cyclic AMP metabolism in human bronchial asthma. 3. Leukocyte and lymphocyte responses to steroids.

Authors:  C W Parker; M G Huber; M L Baumann
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

7.  Alterations in cyclic AMP metabolism in human bronchial asthma. II. Leukocyte and lymphocyte responses to prostaglandins.

Authors:  C W Parker; M L Baumann; M G Huber
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

Review 8.  Combination bronchodilator therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

9.  Comparison between the effects of inhaled isoprenaline and fenoterol on plasma cyclic AMP and heart rate in normal subjects.

Authors:  A J Fairfax; M Rehahn; D Jones; B O'Malley
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

10.  Defective histamine release in chronic urticaria.

Authors:  F Kern; L M Lichtenstein
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.